Locations:
Search IconSearch

Neurosciences

Self-portrait
July 15, 2019/Neurosciences/Research

Tardive Dyskinesia Therapy Holds Up Over Long-Term Assessment

Extension study of VMAT2 inhibitor helps confirm a new therapeutic era

AMI-Tuck-1642295     06-25-19

Therapeutic Arts Program Aims to Make Patients Resilient in the Face of Multiple Sclerosis

Early results with ‘HeRe We Arts’ spur testing in a randomized trial

19-NEU-3860-alzheimer-brain-650×450
July 10, 2019/Geriatrics

Cleveland Alzheimer’s Disease Research Center to Be Created With $4.23 Million NIA Grant

Local population, deep expertise portend a center with high impact

19-NEU-518-epilepsy-brain-650×450

Summit Offers Window Into Developments in Focal Cortical Dysplasia Ahead of Major Classification Update

3-day course to convene world experts on this diverse group of focal epilepsies

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

19-NEU-450-mitochondrion-650×450

Let’s Retire the Term ‘Possible’ Mitochondrial Disease

Experts urge using ‘diagnosis uncertain’ and describing abnormalities instead

19-HRT-3843-Neuroimaging-Evaluate-Syncope

Is Neuroimaging Necessary to Evaluate Syncope?

A case lesson in how best to supplement the history and examination in this setting

19-NEU-516-functional-movement-disorder-650×450

Case Study: When Functional Disorder Meets Organic Disorder

Woman with myoclonic-like movements benefits from interdisciplinary therapy

19-NEU-462-DeSilva-Leverenz-Alzheimers-CQD-650×450

Probing the Innate Immune System’s Role in Alzheimer’s Disease

Interdisciplinary research aims to glean insights for therapeutic translation

BackPage 55 of 113Next

Advertisement

Ad